- Report
- February 2025
- 200 Pages
Global
From €3948EUR$4,490USD£3,402GBP
- Report
- September 2024
- 312 Pages
Global
From €4396EUR$5,000USD£3,788GBP
- Report
- April 2025
- 250 Pages
Global
From €3948EUR$4,490USD£3,402GBP
- Report
- April 2025
- 200 Pages
Global
From €3948EUR$4,490USD£3,402GBP
- Report
- March 2025
- 200 Pages
Global
From €3948EUR$4,490USD£3,402GBP
- Report
- January 2025
- 175 Pages
Global
From €3948EUR$4,490USD£3,402GBP
- Report
- January 2025
- 175 Pages
Global
From €3948EUR$4,490USD£3,402GBP
- Report
- January 2025
- 175 Pages
Global
From €3948EUR$4,490USD£3,402GBP
- Report
- January 2025
- 175 Pages
Global
From €3948EUR$4,490USD£3,402GBP
- Report
- January 2025
- 175 Pages
Global
From €3948EUR$4,490USD£3,402GBP
- Report
- July 2025
- 390 Pages
Global
From €5143EUR$5,850USD£4,432GBP
- Report
- July 2025
- 402 Pages
Global
From €5143EUR$5,850USD£4,432GBP
- Report
- July 2025
- 466 Pages
Global
From €5143EUR$5,850USD£4,432GBP
- Report
- July 2025
- 274 Pages
Global
From €5143EUR$5,850USD£4,432GBP
- Report
- July 2025
- 402 Pages
Global
From €5143EUR$5,850USD£4,432GBP
- Report
- July 2025
- 492 Pages
Global
From €5143EUR$5,850USD£4,432GBP
- Report
- July 2025
- 286 Pages
Global
From €5143EUR$5,850USD£4,432GBP
- Report
- July 2025
- 383 Pages
Global
From €5143EUR$5,850USD£4,432GBP
- Report
- July 2025
- 471 Pages
Global
From €5143EUR$5,850USD£4,432GBP
- Report
- July 2025
- 406 Pages
Global
From €5143EUR$5,850USD£4,432GBP

The Eye Disease market within the Optical industry is a rapidly growing sector, with a focus on providing treatments and solutions for a variety of eye conditions. This includes the diagnosis and management of conditions such as glaucoma, cataracts, macular degeneration, and diabetic retinopathy. Companies in this market are developing innovative technologies to improve the accuracy and speed of diagnosis, as well as treatments to improve patient outcomes.
The Eye Disease market is also focused on providing solutions to improve patient access to care, such as telemedicine and remote monitoring. This is helping to reduce the burden on healthcare systems and improve patient outcomes.
Companies in the Eye Disease market include Alcon, Bausch + Lomb, Carl Zeiss Meditec, Essilor, Hoya, Johnson & Johnson Vision, Novartis, and Topcon. Show Less Read more